Advanced MR Imaging (AMRI) Scan for Brain Lesions

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Brain LesionsStandard of Care Brain Biopsy and Tumor Removal - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The goal of this clinical research study is to learn if using advanced magnetic resonance imaging (AMRI) will improve the targeting of brain tumor needle biopsies compared to the standard targeting techniques. Researchers also want to learn how the results of the images and biopsies compare to each other to try to improve the way researchers and radiologists use AMRI images. This is an investigational study. The perfusion scan is not FDA approved or commercially available. It is currently only being used in research. There will be no cost to you for the advanced MRI, additional anesthesia, special pathology stains, and/or gene testing for this study. Up to 50 patients will take part in this study. All will be enrolled at MD Anderson.

Eligible Conditions
  • Brain Lesions

Treatment Effectiveness

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 2 weeks

2 weeks
Comparison of the Accuracy of the Pathological Grades of Tumor Observed at the Biopsy Locations Identified Using Conventional Versus Advanced Imaging
Target Sample Grading

Trial Safety

Trial Design

1 Treatment Group

Advanced MR Imaging (AMRI) Scan
1 of 1

Experimental Treatment

50 Total Participants · 1 Treatment Group

Primary Treatment: Advanced MR Imaging (AMRI) Scan · No Placebo Group · N/A

Advanced MR Imaging (AMRI) ScanExperimental Group · 2 Interventions: Standard of Care Brain Biopsy and Tumor Removal, Advanced Magnetic Resonance Imaging Scan · Intervention Types: Procedure, Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 weeks

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,802 Previous Clinical Trials
1,788,849 Total Patients Enrolled
Dawid Schellingerhout, MDPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
3 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: